Participated · Equity · Aug 2026

AssistMe develops alea, a medical device and integrated care platform that provides event-based, actionable information such as incontinence events, body signals, posture and location to support care professionals in elderly care. Alea is already in use across care homes in eight European countries, where it helps tailor care to individual needs by making otherwise hidden events visible. The company plans further product development, broader expansion across Europe, preparation for US market entry, and expansion of alea into home care. AssistMe’s leadership includes CEO Julio Brandl and CFO Alexander Meiritz, who led the company through the recent financing. The company raised €6.5 million in the announced round to fund these initiatives, backed by both new and existing investors including CRB Health Tech SGEIC and Vorwerk Ventures.

Participated · Series A · Mar 2026

Kupando develops therapies addressing unmet needs in cancer and infectious diseases by harnessing innate immune stimulation and induction of trained innate immunity via dual Toll‑Like Receptor (TLR) agonists. Its lead candidate, KUP101, is a differentiated dual TLR4 and TLR7 agonist with a preclinical profile and a stated clear path to the clinic. The company plans to use the newly raised Series A funds to advance KUP101’s Phase 1b clinical study in advanced solid tumors and to accelerate its infectious‑disease preclinical programs. Kupando is led by CEO and Founder Johanna Holldack and is based in Schönefeld, Germany. Financially, the latest €10M Series A tranche brought the total capital raised to $23M.

Participated · Seed · Dec 2025

Founded in 2022 by Dr. Hans Lennartz and Leopold von Schultzendorff, Potsdam-based Doctorflix delivers certified continuing-education content for healthcare professionals via an on-demand platform. The service already claims the highest content density of certified medical training videos in Germany and has secured content partnerships with leading hospitals such as Charité and the Median-Kliniken. Delivered through video, podcast and micro-learning formats, the content is designed to fit the time-pressed schedules of doctors and, soon, nurses and medical assistants. Doctorflix’s goal is to evolve into the world’s largest repository for medical learning resources, removing geographic, linguistic and economic barriers for clinicians. With the fresh capital the company will add new professional disciplines like nursing and accelerate international expansion. Since launch, Doctorflix has raised a total of €4.1 million in seed financing, backed by both corporate and financial investors.

Participated · Equity · Nov 2025

Captain T Cell is a biotech spin-off from the Max Delbrück Center for Molecular Medicine that is building a pipeline of tumour-targeting TCR-T cell therapies. Its lead autologous candidate, CTC127, targets the MAGE-A4 antigen and will enter the TOMATA Phase I trial across nine German cancer centres, addressing lung, bladder, gastro-oesophageal, ovarian, and head-and-neck cancers. The company’s engineering “toolbox” adds functional armouring to T cells to enhance anti-tumour activity, persistence, and resilience within the solid-tumour microenvironment. In parallel, Captain T Cell is advancing a first-in-class allogeneic “off-the-shelf” TCR-T platform that has shown complete tumour responses in pre-clinical in-vivo studies. Management also plans to extend the toolbox toward in-vivo T-cell therapy applications. With the newly secured capital, the TOMATA trial is fully funded and the allogeneic program is positioned for clinical readiness, giving the firm multiple upcoming value-inflection points. Including earlier grants, Captain T Cell now has €20 million of available funding to execute its near-term clinical plans.

Participated · Equity · Jul 2025

Founded in 2024 and based in Berlin, ALVA Energie develops landlord-to-tenant electricity and decentralised energy solutions for residential and commercial property owners and tenants. The company offers a vertically integrated 360° business model covering planning, financing, installation and ongoing operations, with options including flexible roof leases, system leases and certain supply chain operator models. Under the KARLSSONN brand it supplies tenants with on-site green electricity produced directly where they live. Since its foundation roughly 18 months ago ALVA says it has profitably grown to be a multi‑million euro revenue company and has completed over 50 projects to date. The firm aims to double the number of projects by the end of the year and reports those projects have so far saved almost 6,000 tons of CO2. ALVA plans to scale its landlord-to-tenant offerings across Germany through partnerships with private owners, larger real estate companies and investment funds.